Margaret McLoughlin - 08 Oct 2021 Form 4 Insider Report for Cortexyme, Inc. (QNCX)

Role
Director
Signature
/s/ Caryn Gordon McDowell, Attorney-in-Fact for Margaret McLoughlin
Issuer symbol
QNCX
Transactions as of
08 Oct 2021
Net transactions value
-$71,930
Form type
4
Filing time
12 Oct 2021, 17:48:46 UTC
Previous filing
18 Aug 2021
Next filing
09 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Stock Options Exercise $17,000 +1,000 $17.00* 1,000 08 Oct 2021 Direct
transaction QNCX Common Stock Sale $88,930 -1,000 -100% $88.93* 0 08 Oct 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Stock Option (right to buy) Options Exercise $0 -1,000 -1.2% $0.000000 84,911 08 Oct 2021 Common Stock 1,000 $17.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 4, 2021.
F2 The option vested as to 1/3rd of the shares on May 8, 2020, with the remaining 2/3rd of shares vesting in equal monthly installments beginning on June 8, 2020 and ending on May 8, 2022.